News & Perspective

Apr 23, 2012

Apr 23, 2012

Study: Mexico's H1N1 mortality rose as antiviral use dropped

(CIDRAP News) – A large-scale study suggests that antiviral treatment saved many lives during Mexico's 2009 H1N1 influenza pandemic but also points to an irony: that the use of antivirals dropped sharply in the fall wave of cases.

Apr 11, 2012

Apr 09, 2012

Apr 09, 2012

H1N1 cases in India sparking media hype

(CIDRAP News) – Reports of sporadic 2009 H1N1 infections and a few deaths in parts of India have sparked high-profile media coverage of the disease in the country, catching the attention of public health officials and vaccine makers, according to several media reports.

Apr 06, 2012

Apr 06, 2012

Impact of IV peramivir use in 2009 pandemic unclear

(CIDRAP News) – The intravenous antiviral peramivir was used in close to 1,300 severely ill patients under an emergency authorization during the 2009 flu pandemic, but its impact and safety profile remain unclear, in part because of patchy data collection, according to reports and commentary published in Clinical Infectious Diseases (CID) this week.

Apr 05, 2012

Apr 05, 2012

Study: Lax response spurred England's late, severe H1N1 spike

(CIDRAP News) – Lapses in health measures during the second season that the 2009 H1N1 flu virus circulated in England probably contributed to a heavier disease burden—marked by more deaths and hospitalizations—than during the 2009-10 pandemic, researchers reported today.

Mar 29, 2012

Mar 29, 2012

Studies confirm H1N1 vaccine-narcolepsy link in Finnish kids

(CIDRAP News) – Two studies yesterday confirmed the link between narcolepsy in Finnish children and the adjuvanted 2009 H1N1 pandemic vaccine Pandemrix and offered new details.

Pages

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get news & practices.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M United Health Foundation Gilead Become an underwriter»